Oxford/AstraZeneca jab could have causal link to rare blood clots, say UK experts

Evidence ‘consistent with causality’ but vaccination programme must continue, says drug safety specialist

Boris Johnson has sought to reassure people about the safety of the Oxford/AstraZeneca Covid vaccine as a trial in children was paused while regulators investigate rare reports of blood clots, largely in younger women.

The prime minister urged the public to take the jab when it is offered, while scientists stressed the side-effects were extremely rare and the benefits of protection against coronavirus were great.

Continue reading…

Next Post

UK public health expert Sir Michael Marmot criticises No 10 race report ‘shortcomings’

Thu Apr 8 , 2021
Sir Michael Marmot says racial disparities report underplays impact of structural racism in health outcomes Michael Marmot: The Sewell report cited my research. Unfortunately, it was out of date Coronavirus – latest updates An inquiry into racial disparities used outdated references and notably underplayed the impact of structural racism in […]

You May Like